Chris Chiu retweeted
Are you developing a next-generation SARS-CoV-2 vaccine?
The MusiCC consortium are looking for vaccine developers who are interested in providing vaccine candidates for a COVID-19 human challenge study
Find out more: musicc.org/
Looking for an enthusiastic clinician interested in expanding their research experience working on exciting translational #covid19, #influenza & #rsv studies to develop better #vaccines! jobs.ac.uk/job/DIK544/clinic…
Looking for a great #research #nurse to join our team, working on world-leading studies of respiratory viral infections & #vaccines. All training given, so fantastic opportunity to develop new skills! Clinical Research Nurse at Imperial College London (jobs.ac.uk)
We are looking for healthy volunteers aged 30-55 to take part in a COVID-19 inhaled booster vaccine trial involving 12 visits over 12 months. You will be compensated up to £1,010 for your time. Contact [email protected]
#WorldImmunisationWeek
Looking to use your people and organisational skills to help with ground-breaking clinical research studies of #flu, #RSV and #SARS_CoV_2? Join our fantastic multi-disciplinary team! imperial.ac.uk/jobs/descript…
New year, new job?! Looking for a clinician interested in doing some cutting-edge infection research using #humanchallenge with #COVID19. Join a fantastic multi-disciplinary team doing something truly unique. For more info: bmj.com/careers/job/171331/c…
Are you a clinician interested in #infection? Join our #multidisciplinary team working on #COVID19 #humanchallenge, performing unique research in a fantastic environment! bmj.com/careers/job/171331/c…
Chris Chiu retweeted
Quote: "Based on the correlates of protection against new Omicron BA.4/5 infections, protection was lower and shorter after a third/booster vaccination, but higher and longer after breakthrough infection, especially among younger individuals."
Wonderful study from @drdavideyre et al using @ONS infection survey data
After 2x vaccine, infection or booster vaccine increase protection vs BA.4/5
Waning is rapid after boosters but highly durable after infection
Hybrid immunity is most durable
medrxiv.org/content/10.1101/…
Are you a #nurse looking to join a fantastic multidisciplinary #research team doing unique experimental medicine studies on #COVID19 and other #respiratory #viral #infections? Apply now! Deadline is tomorrow! jobs.ac.uk/job/CUA723/resear…
Chris Chiu retweeted
How do you engage members of the public with medical research? In our latest Medicine blog, Dr Emma Smith, @hic_vac Network Manager, outlines how consulting the public was crucial during the world’s first #COVID-19 human challenge study.
blogs.imperial.ac.uk/imperia…
Chris Chiu retweeted
🎧 On this week’s @BBCRadio4's Inside Health, Dr Ryan Thwaites (@InThwaiteImmune) discusses what the options are for those who are immunocompromised and still vulnerable to the threat of Covid. From 11min. ow.ly/NVNh50LhACT
Chris Chiu retweeted
Opening the second day of the @hic_vac meeting with a session on challenge models in a pandemic setting, excited to hear from @ChrisChiuLab reflecting on the SARS-CoV-2 model
Chris Chiu retweeted
We are looking for healthy volunteers to take part in our COVHIC002 study. If you are aged 18-30, have been vaccinated against COVID-19 and you are in good health, visit: imperial.ac.uk/infectious-di… to find out more. You will be paid up to £4,470 for your time and inconvenience.
My team is growing and we need #ResearchNurses to help with our unique #COVID #HumanChallenge studies! No research experience needed as we will train, but motivated teamplayers with solid clinical skills, please apply: imperial.ac.uk/jobs/descript…
Chris Chiu retweeted
Volunteers for the malaria trial put an arm over a box with hundreds of mosquitoes carrying a genetically modified malaria parasite. Here's why they did it that way — and why the trial holds promise. n.pr/3qUluBt
Chris Chiu retweeted
Recent @UKCICstudy-supported work highlighting the need to develop vaccines that enhance nasal immunity
👇
uk-cic.org/publication/nasal…
Nasal IgA wanes 9 months post-infection and is minimally impacted by subsequent vaccination.
@p_openshaw @LanceTurtle @CCPUKstudy @InThwaiteImmune
Chris Chiu retweeted
Really great to see Prof @ChrisChiuLab presenting our lab's elderly RSV challenge work at the @rsv2022 conference in Belfast #HIC #RSV

















